Aurinia Pharmaceuticals (AUPH) Non Operating Income (2020 - 2024)
Aurinia Pharmaceuticals (AUPH) posted Non Operating Income of $4.2 million for Q2 2024, down 7.45% on a QoQ basis from $4.5 million in Q1 2024, and up 2.15% year-over-year from $4.1 million in Q3 2023.
Aurinia Pharmaceuticals (AUPH) Non Operating Income (2020 - 2024) Analysis & Trends
Aurinia Pharmaceuticals' Non Operating Income history runs 5 years deep, the most recent figure standing at $4.2 million for Q2 2024.
- Quarterly Non Operating Income rose 2.15% year-over-year to $4.2 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $17.8 million (up 44.83% YoY) and the FY2023 annual result came in at $17.0 million, up 232.1% from the prior year.
- Non Operating Income was $4.2 million for Q2 2024 at Aurinia Pharmaceuticals, down from $4.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $4.6 million in Q4 2023 and bottomed at $106000.0 in Q3 2021.
- A 5-year average of $2.0 million and a median of $973500.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income plunged 37.65% — and 2022, when it soared 2568.81%.
- Aurinia Pharmaceuticals' Non Operating Income stood at $135000.0 in 2020, then retreated by 19.26% to $109000.0 in 2021, then surged by 2568.81% to $2.9 million in 2022, then jumped by 57.03% to $4.6 million in 2023, then declined by 8.3% to $4.2 million in 2024.
- Business Quant data shows AUPH's Non Operating Income at $4.2 million in Q2 2024, $4.5 million in Q1 2024, and $4.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.19 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 4.57 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 483,000.00 |
| Mar 31, 2022 | 262,000.00 |
| Dec 31, 2021 | 109,000.00 |
| Sep 30, 2021 | 106,000.00 |
| Jun 30, 2021 | 142,000.00 |
| Mar 31, 2021 | 172,000.00 |
| Dec 31, 2020 | 135,000.00 |
| Sep 30, 2020 | 170,000.00 |